CADHERIN DYNAMICS AND GLAUCOMA
钙粘蛋白动力学和青光眼
基本信息
- 批准号:7761661
- 负责人:
- 金额:$ 33.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-02 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adherens JunctionAdhesionsAnteriorAqueous HumorAreaBindingBiological ModelsBiologyBiomechanicsBlindnessBlood VesselsCadherinsCalciumCell Adhesion MoleculesCell-Cell AdhesionCellsClinical TrialsComplexCountryDataDevelopmentDrainage procedureEndothelial CellsEndotheliumExtracellular DomainExtracellular MatrixFamilyGenerationsGenesGlaucomaGoalsHumanIndividualIntercellular JunctionsInvestigationKnowledgeLaboratoriesMaintenanceMechanicsMediatingMolecularMolecular and Cellular BiologyMonitorOcular HypertensionOpen-Angle GlaucomaOutcomePathway interactionsPatientsPerfusionPermeabilityPharmacologic SubstancePhosphorylationPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProteinsPublishingQualifyingReceptor ActivationReceptor SignalingRecording of previous eventsRegulationRelative (related person)ResearchResearch PersonnelResistanceRoleSignaling ProteinSiteSphingosine-1-Phosphate ReceptorStretchingStructureStructure of sinus venosus of scleraTechnical ExpertiseTestingTimeTissuesVisionWorkaqueousbasecadherin 5designeffective therapyexperienceextracellularinnovationmembernew therapeutic targetnovelpressureprogramsprotein expressionprotein protein interactiontool
项目摘要
Recent clinical trials demonstrate that significant, sustained intraocular pressure reduction in people with
glaucoma slows or halts vision loss, even in patients with low-tension glaucoma. While the site of increased
resistance in glaucoma is likely located in the conventional drainage pathway, the cellular mechanisms
responsible for generation of this extra resistance are unknown. Previous work points to two possibilities that
are not mutually exclusive: (i) abnormal accumulation and/or alterations in the extracellular matrix materials
of the juxtacanalicular tissue; or (ii) alterations in the function of the intercellular junctions (and associated
border pores) of the inner wall of Schlemm's canal.
In the present application, we propose to study a family of cell-cell adhesion molecules, the cadherins, in the
endothelial cells of Schlemm's canal. Cadherins form adherens junctional complexes, which are present in
the conventional drainage pathway, but have only been described morphologically. Since homophilic protein-
protein interactions of cadherin extracellular domains on adjacent cells are critical to the formation and
maintenance of the integrity of at least three intercellular junctional complexes (including adherens,
occludens and gap), and published evidence suggests that cell-cell adhesion plays a role in determining
outflow resistance, we hypothesize that cadherins between Schlemm's canal endothelia strongly influence
the generation of outflow resistance.
Our study will examine cadherins at the molecular and functional levels and (i) specifically target cadherin-5
(plus associated catenin proteins) and disrupt adhesion between Schlemm's canal endothelia; (ii)analyze
effects of pressure differences/stretch on relative expression levels, subcellular distribution and
phosphorylation status of cadherin-5 plus associated catenins; and (iii) monitor signaling proteins that
regulate the formation and remodeling of the cadherin-5 junction complex. Results obtained from these
investigations will provide a basic understanding of the role of cadherin proteins in aqueous outflow
resistance and uncover novel therapeutic targets for glaucoma therapy.
最近的临床试验表明,显著,持续的眼内压降低,
青光眼减缓或阻止视力丧失,即使是低眼压性青光眼患者。虽然网站的增加
青光眼中的阻力可能位于传统的引流途径,细胞机制
负责产生这种额外的阻力是未知的。以前的工作指出了两种可能性,
(i)细胞外基质物质的异常积累和/或改变
(ii)细胞间连接功能的改变(以及相关的
Schlemm管内壁的边缘孔)。
在本申请中,我们提出研究细胞-细胞粘附分子家族,钙粘蛋白,其在细胞中的表达。
Schlemm管内皮细胞。钙粘蛋白形成粘附连接复合物,其存在于
传统的引流途径,但仅在形态学上进行了描述。因为嗜同性蛋白质-
钙粘蛋白胞外结构域与相邻细胞的蛋白质相互作用对于钙粘蛋白的形成和
维持至少三种细胞间连接复合物(包括粘附物,
occludens和gap),已发表的证据表明,细胞-细胞粘附在决定
流出阻力,我们假设Schlemm管内皮细胞之间的钙粘蛋白强烈影响
流出阻力的产生。
我们的研究将在分子和功能水平上研究钙粘蛋白,(i)特异性靶向钙粘蛋白-5
(plus相关的连环蛋白),并破坏施累姆氏管内皮细胞之间的粘附;(ii)分析
压力差/拉伸对相对表达水平、亚细胞分布和
钙粘蛋白-5加上相关连环蛋白的磷酸化状态;和(iii)监测
调节钙粘蛋白-5连接复合物的形成和重塑。从这些获得的结果
调查将提供一个基本的了解钙粘蛋白蛋白的作用,在水流出
并发现青光眼治疗的新治疗靶点。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human Schlemm's canal endothelial cell monolayers.
1-磷酸鞘氨醇增强培养的人施累姆氏管内皮细胞单层中的皮质肌动球蛋白组织。
- DOI:10.1167/iovs.10-5391
- 发表时间:2010
- 期刊:
- 影响因子:4.4
- 作者:Sumida,GrantM;Stamer,WDaniel
- 通讯作者:Stamer,WDaniel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W Daniel Stamer其他文献
W Daniel Stamer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W Daniel Stamer', 18)}}的其他基金
"Concepts and Breakthroughs in Glaucoma" Conference
“青光眼的概念与突破”会议
- 批准号:
10317233 - 财政年份:2021
- 资助金额:
$ 33.56万 - 项目类别:
Basic Science Catalyzing Treatments for Glaucoma
青光眼的基础科学催化治疗
- 批准号:
9391815 - 财政年份:2017
- 资助金额:
$ 33.56万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 33.56万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 33.56万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 33.56万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 33.56万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 33.56万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 33.56万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 33.56万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 33.56万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 33.56万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 33.56万 - 项目类别:














{{item.name}}会员




